Heart Failure With Preserved Ejection Fraction in Women: New Clues to Causes and Treatment
- PMID: 32215378
- PMCID: PMC7091503
- DOI: 10.1016/j.jacbts.2020.02.001
Heart Failure With Preserved Ejection Fraction in Women: New Clues to Causes and Treatment
Keywords: HFpEF; HFrEF; PDE5; contractility; diastolic; estrogen; estrogen receptors; fibrosis; heart failure; hormone therapy; menopause; myocardial; phosphodiesterase-5; signaling; sildenafil; systolic.
Comment on
-
Estrogen Receptor-α Non-Nuclear Signaling Confers Cardioprotection and Is Essential to cGMP-PDE5 Inhibition Efficacy.JACC Basic Transl Sci. 2020 Mar 4;5(3):282-295. doi: 10.1016/j.jacbts.2019.12.009. eCollection 2020 Mar. JACC Basic Transl Sci. 2020. PMID: 32215350 Free PMC article.
References
-
- Meyer M.R., Barton M. Estrogens and coronary artery disease: new clinical perspectives. Adv Pharmacol. 2016;77:307–360. - PubMed
-
- Rodrigues Sabbatini A.R., Kararigas G. Menopause-related estrogen decrease and the pathogenesis of HFpEF: JACC Review Topic of the Week. J Am Coll Cardiol. 2020;75:1074–1082. - PubMed
Publication types
LinkOut - more resources
Full Text Sources